Recruiting NA Labor Dystocia

New treatment option for Labor Dystocia

Official title The Norwegian World Health Organisation Labour Care Guide Trial (NORWEL)

ClinicalTrials.gov ID: NCT05791630

What this study is testing

What it's testing
Appropriate and timely care during birth is critical to the survival and health of women and their babies. In 2020, the World Health Organization (WHO) presented the Labour Care Guide (LCG) as the new recommended tool for monitoring birth and assessing progression, replacing the WHO partograph.
  • Which group you join is decided by chance.

A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.

Who can take part

Ages 18 and older, women only. Healthy volunteers may be eligible.

You may be able to join if

  • Women in active labour
  • Labour and delivery at study sites

You likely can't join if

  • None

The study team makes the final eligibility decision.

Where it's taking place

  • Nordbyhagen, Akershus, Norway
  • Drammen, Buskerud, Norway
  • Kristiansand, Kristiansand, Norway
  • Oslo, Oslo, Norway
  • Stavanger, Rogaland, Norway
  • Tromsø, Troms, Norway
  • Trondheim, Trøndelag, Norway
  • Bergen, Vestland, Norway
  • Greåker, Østfold fylke, Norway

Questions & answers

Do participants get paid in this trial?

This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.

Is it free to join, and do I need insurance?

Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.

How long does this study last?

The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.

Who can join this trial?

This study is enrolling female, 18 years and older. Healthy volunteers may be eligible. The study team makes the final eligibility decision.

Where is this trial taking place?

Study sites include Nordbyhagen, Akershus, Norway; Drammen, Buskerud, Norway; Kristiansand, Kristiansand, Norway; Oslo, Oslo, Norway; Stavanger, Rogaland, Norway; Tromsø, Troms, Norway and 3 more location(s). Enter your location above to see the nearest site and check your eligibility.

Explore other conditions

BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.